期刊文献+

胃肠间质瘤56例临床诊治分析 被引量:3

Diagnosis and Treatment of 56 Cases with Gastrointestinal Stromal Tumors
下载PDF
导出
摘要 目的总结胃肠间质瘤(GIST)的临床病理特征,探讨外科治疗效果并评价不同部位GIST的预后。方法对川北医学院附属医院自2001年12月到2007年12月外科收治的56例GIST患者的临床病理资料进行回顾性分析并作随访。结果56例GIST术前无一例确诊。肿瘤发生部位:胃27例,小肠11例,其他部位18例。6例首诊已出现转移,其中5例为胃外GIST。10例呈明显浸润生长,其中9例为胃外GIST。免疫组织化学检测:CD117阳性率97.1%,CD34阳性率87.5%。术后随访时间5~75个月,总获访率71.4%(40/56),28例无瘤健在,5例带瘤生存,7例于术后2~20个月死亡。死亡病例主要为胃外GIST,且为首诊转移或明确浸润生长者。结论GIST术前确诊困难,CD117和CD34是病理确诊的重要标志物。肿瘤的大小及生长方式与肿瘤的发生部位相关。肿瘤的预后与其发生部位、生长方式及首诊转移有关。治疗仍以外科手术为主,但高度恶性的GIST单纯外科治疗预后差。 Objective To summarize the clinical and pathological characteristics and analyze the relationship between tumors′ location and their prognosis,and the efficacy of surgical management.Methods The clinical and pathological data of 56 cases with GISTs admitted to surgical department of hospital affiliated to North Sichuan Medical College from Dec.2001 to Dec.2007 were collected.Their pathological features,clinical manifestations and especially the surgical outcomes were analyzed retrospectively.Results None of the 56 cases'preoperative diagnosis was definite.Of the 56 cases,27 cases occurred in stomach,11 in small intestine and 18 occurred in other sites.6 cases of first diagnosis were discovered to have metastasized,5 cases among them were tumors growing out of stomach.10 cases invaded the adjacent organs or tissues obviously and 9 of them were intestinal GISTs.The positive rates for CD117and CD34were 97.1%and 87.5%respectively.The follow-up was obtained successfully in 40 cases(71.4%),and lasted 5-75 months.Of the 40 cases,28 were still alive without tumors,5 survived with tumors and 7 died within 2-20 months after surgical management.The 7 died cases were mainly derived from intestinal tract and invaded the adjacent organs or tissues obviously.Conclusion Definite preoperative diagnosis is hard to get.CD117and CD34are sensitive markers for the finally definite diagnosis by pathology.The tumor′s size and growth pattern are relevant to its occurrence location,and the occurrence location of tumors and its growth pattern,preoperative metastasis are relevant to the prognosis of GISTs.Surgical management is the effective choice of treatment for GISTs,however,the efficacy of surgical management with GIST of high malignant degree is poor.
出处 《医学综述》 2010年第7期1114-1116,共3页 Medical Recapitulate
基金 川北医学院大学生科创基金(081113)
关键词 胃肠间质瘤 外科治疗 预后 Gastrointestinal stromal tumors; Surgical management; Prognosis
  • 相关文献

参考文献19

  • 1Mazur MT,Clark HB. Gastric stromal tumors. Reappraisal of histogenesis[ J]. Am J Clin Pathol, 1983,7 (6) :507-519.
  • 2Hirota S, Ioszaki K, Moriyama Y, et ul. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [ J ]. Science, 1998,279 (5350) :577-580.
  • 3De Matteo RP, Lewis J J, Leung D,et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J]. Ann Surg,2000,231 ( 1 ) :51-58.
  • 4Plaat BE, Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors:differences in clinical outcome and expression of multidrug resistance proteins [J]. J Clin Oncol,2000,18(18) :3211-3220.
  • 5牛洪欣,何庆泗.胃肠道间质瘤现代研究进展[J].中国普通外科杂志,2007,16(9):895-897. 被引量:20
  • 6Miettinen M, Sarlomo-Rikala M, Lassota J. Gastrointestinal stromal tumors: rece-nt advances in umterstanding of their biology [ J ]. Hum Pathol, 1999,30 ( 10 ) : 1213 - 1220.
  • 7Sarlomo-Rikala M, Kovatich A J, Barusevicius A, et al. CD117 : a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34[J]. Mod Pathol, 1998,11 ( 8 ) :728-734.
  • 8Rubin BP, Fletcher JA, Fletcher CD. Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors [J]. Int J Surg Pathol,2000,8( 1 ) :5-10.
  • 9Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT) [J].Mod Pathol, 2000,13 ( 10 ) : 1134-1142.
  • 10Keun Park C, Lee E J, Kim M, et al. Prognostic stratification of high-risk gastro-intestinal stromal run,ors in the era of targeted therapy[ J]. Ann Surg,2008,247 (6) :1011-1018.

二级参考文献32

  • 1李雪兰,胡忠良,郑长怡,郑辉,文继舫.胃肠道间质瘤的病理与免疫组化特征:附20例报告[J].中国普通外科杂志,2005,14(3):221-224. 被引量:18
  • 2程烽涛,刘玲.胃肠道间质瘤病理及CD117和CD34表达与意义[J].中国病理生理杂志,2006,22(6):1222-1224. 被引量:2
  • 3伍晓汀,夏霖.胃肠道间质瘤的临床诊断和分期[J].中国实用外科杂志,2006,26(8):572-574. 被引量:37
  • 4叶颖江,王杉.胃肠道间质瘤的预后[J].中国实用外科杂志,2006,26(8):591-594. 被引量:8
  • 5Mazur MT,Clark HB.Gatric stromal tumors:reappraisal of histogenesis.Am J Surg Pathol,1983,7:507-519.
  • 6Rosai J.Gastrointestinal tract.Stromal tumors.In:Rosai J,ed.Ackerman's Surgical Pathology,8th.St Louis:MosbyYear Book,Inc,1996.589-814.
  • 7Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.Science,1998,279:577-580.
  • 8Rubin BP,Fletcher JA,Fletcher CD.Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors.Int J Surg Pathol,2000,8:5-10.
  • 9Heinrich MC,Corless CL,et al.PDGFRA activating mutations in GIST.Science,2003,299:708-710.
  • 10Buer S,Corless C,Heinrich MC et al.Response to imatinib mesylate of a GIST with very low expression of KIT.Cancer Chemophamacol,2003,51:261-265.

共引文献54

同被引文献35

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部